Vitreoretinal

Letter issued by FDA to increase awareness of potential risk associated with Medtronic NIM EMG Endotracheal Tube

Potential Risk of Airway Obstruction When Using Certain Electromyogram Endotracheal Tubes – Letter to Health Care Providers Today, the U.S. Food and Drug Administration (FDA) is issuing a Letter to Health Care Providers to increase awareness about the potential risk of airway obstruction when using silicone-based electromyogram (EMG) endotracheal tubes (Medtronic NIM Standard Reinforced EMG…

Learn More

Call Us

Email Us

Business Hours

Store

Backflush Accessories

High Viscosity Injectors

Call Us

Email Us

Business Hours

Letter issued by FDA to increase awareness of potential risk associated with Medtronic NIM EMG Endotracheal Tube

Surgical Tray Inspection/Sharpening Return to Kaiser Roseville